Neuroleptic malignant syndrome.
dc.contributor.author | Bhatia, M S | en_US |
dc.contributor.author | Singhal, P K | en_US |
dc.contributor.author | Bohra, N | en_US |
dc.contributor.author | Kaur, N | en_US |
dc.date.accessioned | 1988-08-01 | en_US |
dc.date.accessioned | 2009-05-27T05:40:01Z | |
dc.date.available | 1988-08-01 | en_US |
dc.date.available | 2009-05-27T05:40:01Z | |
dc.date.issued | 1988-08-01 | en_US |
dc.identifier.citation | Bhatia MS, Singhal PK, Bohra N, Kaur N. Neuroleptic malignant syndrome. Indian Pediatrics. 1988 Aug; 25(8): 788-90 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/12391 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://indianpediatrics.net | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Haloperidol --adverse effects | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Neuroleptic Malignant Syndrome --etiology | en_US |
dc.title | Neuroleptic malignant syndrome. | en_US |
dc.type | Case Reports | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1